Fundz

Insmed Announces Strategic Financings Totaling $775 Million

PUBLIC · INSMOct 19, 2022

Round Type

Funding Round

BridgewaterBiotechnologyHealth CareTherapeutics

Description

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced three strategic financings resulting in aggregate gross proceeds of $775 million. Proceeds from the transactions will strengthen Insmed's financial position, which will place the Company in a position to deliver clinical data from each of its four pillars.

Quick answer

Insmed Incorporated raised an undisclosed amount in a Funding Round round, dated October 19, 2022. Insmed Incorporated is based in Bridgewater, New Jersey, United States.

How much did Insmed Incorporated raise?
Insmed Incorporated raised an undisclosed amount in a Funding Round round on October 19, 2022.
What does Insmed Incorporated do?
Insmed Incorporated is a biopharmaceutical company focused on developing innovative therapies to treat serious and rare diseases.
Where is Insmed Incorporated based and how big is it?
Insmed Incorporated is based in Bridgewater, New Jersey, United States. Fundz records about 1,300 employees.
Who are the decision-makers at Insmed Incorporated?
Fundz holds 1 contact at Insmed Incorporated, including the Associate Director HR. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Insmed Incorporated that raised within 45 days of this round, from Fundz verified event records.

  • Solid Biosciences raised $9.2M on December 2, 2022.
  • RE-VANA THERAPEUTICS raised $12M (Series A) on November 30, 2022.
  • iECURE raised $65M (Funding Round) on November 30, 2022.
  • Nectin Therapeutics raised an undisclosed amount (Series A) on November 30, 2022.
  • Escient Pharmaceuticals raised $120M (Series C) on November 28, 2022.
  • Parabilis Medicines raised $178M (Series D) on November 21, 2022.

Who to call at Insmed Incorporated, and when

A new round usually means Insmed Incorporated is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Insmed Incorporated raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Insmed Incorporated, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Insmed Incorporated. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Insmed Incorporated

Location

700 US Highway 202/206

Bridgewater, New Jersey, United States

About

Insmed Incorporated is a biopharmaceutical company focused on developing innovative therapies to treat serious and rare diseases. The company is committed to addressing unmet medical needs by advancing its proprietary products through clinical development. Insmed's pipeline includes drugs designed to improve patient quality of life. The company operates in various international markets from its headquarters in Bridgewater, New Jersey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Insmed Incorporated raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsVictoria B., Associate Director HR hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Insmed Incorporated's next move

See what Strategic adds

Insmed Incorporated raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.